The House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) recently announced a hearing titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices.” During the hearing, the Chairs highlighted the importance of regularly engaging with FDA officials to understand what is working well and what challenges persist. They also emphasized the need for greater transparency in order to rebuild public trust in government health agencies like the FDA.
The Subcommittee on Health hearing will take place on Wednesday, May 22, 2024 at 10:30 AM ET at 2322 Rayburn House Office Building. The focus of the hearing will be on discussing the regulation of drugs, biologics, and devices by the FDA. Dr. Patrizia Cavazzoni, Director of the Center for Drug Evaluation and Research (CDER) at the FDA, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, and Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH) at the FDA will be among those testifying at